Feb. 23 at 3:31 PM
Going all in on what looks to be the #1 runner-in-waiting. Based on what I'm seeing
$IPDN could see a 100% move before open.
More development on pipeline expansions would persuade me to take a long-term position in
$MRNA and I'll keep on watch for now.
Researching
$JJSF seasonal promotion schedule; there is a predictable pattern of short-term momentum around sales that I believe can provide a series of easily profitable trades, just need to do a little legwork.
$SKE any words here?
$50 Mil flow-through? Speechless.